Business of Nippon Kayaku Group

• Develop excellent pharmaceuticals and medical devices that provide new diagnostic and treatment opportunities
• Stable supply of Biosimilars and generic drugs, contributing to people’s health

• Recovery of worldwide automobile production from the impact of COVID-19, and mitigation of the semiconductor shortage
• The installation rate of safety components is increasing, primarily in emerging countries
• Growing new demand due to EVs, etc.
• Expansion of applications such as drone transportation, etc., and demands for safety assurances

• Technology and inherited expertise to handle explosives safely
• Industry top-level market share in automotive safety components
• Global expansion of locations

• Expansion of production bases for cylinder-type inflators (Japan, China, Malaysia)
• Expand of sales to customers in China and South Korea
• Developing next-generation inflators

• Securing next-generation module projects from customers
• Securing increased volume projects, such as for rear seats
• Expansion of applications such as pedestrian protection and electric current shut-off
• Consideration of new pyro device applications

• Expansion of sales of PARASAFE® for 25kg drones
• Development and market launch of PARASAFE® for 15kg drones
• Development of safety parts for flying cars and large drones

• Evolution and expansion of automotive display functions
• Growing demand for recycling rare metals

• Optical and electromagnetic wave control technologies and microfabrication technologies
• Proprietary highdurability dye synthesis technologies for polarizers

Light-controlling products made from proprietary materials contributing to the realization of a Super Smart Society

• Expansion of new applications for X-ray analysis device parts / materials and inorganic polarizers
• Expansion of new in-car applications of highly durable polarizers such as parts / materials for HUDs

• Synergies in semiconductorrelated products
• Design of functional molecules

Providing important and unique materials

• Expansion in semiconductor-related business areas such as substrates, encapsulants, cleaners, and manufacturing equipment
• Development and launch of resins for use in next-generation communications equipment (low-dielectric materials)
• Expansion of epoxy resin production capacity

• Expansion of the digital printing market
• Expansion of the sensing market
• Expansion of the dimming glass market

• Extensive colorant technologies covering a wide span of fields from traditional dyes to functional colorants
• Precision organic synthesis

Contribution to digitalization and resource conservation with our inkjet colorants and functional colorants

• Expansion of industrial inkjet inks, improvement of production systems
• Mass production and expansion of imaging sensor materials
• Mass production and expansion of dichroic colorants

• Acrylic acid and methacrylic acid markets continue to grow by 5 to 6%
• Expansion of the carbon neutrality-related market

• Optimal customization of catalyst composition and technical services

Providing catalysts with high-yield to contribute to CO₂ reduction and affluent lives

• Improvement of catalysts for higher yields of acrolein, acrylic acid, and methacrylic acid
• Secure repeat orders and development of new customers
• Development of catalysts contributing to a carbon-neutral society

• Pharmaceutical industry vision (quality and stable supply, manufacturing and sales, bio-pharmaceuticals, domestic manufacturing and development, encouraging use)
• Expansion of the CDMO market
• Annual drug price revisions

• Consistent business operation from R&D to manufacturing, sales, quality assurance, pharmacovigilance and post marketing surveillance
• Top domestic anti-cancer drugs lineup and specialized MR
• Manufacturing technology for highly pharmacologically active substances

• Increasing share for ALAGLIO® in TURBT^*
• Maximizing value through drug fostering and evolution

• *TURBT: Transurethral Resection of Bladder Tumor (surgery to remove bladder tumors using an endoscope and excision loop)

• Market spread of bevacizumab BS
• Measures to promote biosimilars through the revision of medical fees
• Expansion of lineup through introduction of new biosimilars

• Enhancement of stable supply and quality assurance system
• Development and launch of the new generic drugs

Enhancement of pipeline

• Development of new drugs in collaboration with external organizations
• Introduction of new drugs and medical devices

• Domestic crop protection market remains at the current level, overseas crop protection market is growing due to increased demand for food
• Introduction of an agrochemical re-evaluation system has raised the bar for obtaining and maintaining domestic agrochemical business registration
• Strategy “MeaDRI” (Sustainable Food Systems) promotes innovation that enables the reduction of agrochemicals (risk conversion)

• Insecticides and soil fumigants in the vegetable and fruit tree domain
• Formulation knowhow (innovative formulations)
• Operating activities combining technical services and information provision
• Manufacturing technologies (from raw ingredients to product formulation)

• Flometoquin formulations (FINESAVE®), expansion of FUMON®
• Expansion of sales by expanding the scope of agrochemical registration
• Response to the agrochemical re-evaluation system for DIAZINON® and other agrochemicals

• Rebuilding the EVISECT® business by restructuring the supply chain
• Registering and expanding sales of Flometoquin preparations

• Development of new insecticides and new innovative formulations
• Development and introduction of biostimulants